Cargando…
Loss of DEK Expression Induces Alzheimer’s Disease Phenotypes in Differentiated SH-SY5Y Cells
Alzheimer’s disease (AD) is the most common cause of dementia and is characterized by the buildup of β-amyloid plaques and neurofibrillary Tau tangles. This leads to decreased synaptic efficacy, cell death, and, consequently, brain atrophy in patients. Behaviorally, this manifests as memory loss and...
Autores principales: | Greene, Allie N., Parks, Lois G., Solomon, Matia B., Privette Vinnedge, Lisa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701170/ https://www.ncbi.nlm.nih.gov/pubmed/33304240 http://dx.doi.org/10.3389/fnmol.2020.594319 |
Ejemplares similares
-
Novel molecular mechanisms in Alzheimer’s disease: The potential role of DEK in disease pathogenesis
por: Greene, Allie N., et al.
Publicado: (2022) -
Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer
por: Pease, Nicholas A., et al.
Publicado: (2015) -
The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer
por: Privette Vinnedge, Lisa M., et al.
Publicado: (2012) -
DEK Expression in Breast Cancer Cells Leads to the Alternative Activation of Tumor Associated Macrophages
por: Pease, Nicholas A., et al.
Publicado: (2020) -
The human DEK oncogene stimulates beta catenin signaling, invasion and mammosphere formation in breast cancer
por: Privette Vinnedge, Lisa M., et al.
Publicado: (2011)